BIVDA Press Releases


IVD Industry Launches 2017 General Election Manifesto

Increasing the adoption of in vitro diagnostics (IVDs) should be a priority for the next Government, the British In Vitro Diagnostics Association (BIVDA) has stated in its 2017 General Election Manifesto.

Focusing on five key policy areas, the report urges the next Government to prioritise: Securing a more effective and efficient NHS by increasing the adoption of IVDs, Guaranteeing patient access to molecular diagnostics, Securing a new mechanism for the funding of IVDs, Playing a leading role in overcoming global health challenges and Establishing a new relationship with the EU.

The manifesto also includes background on the value IVDs deliver for patients, the NHS and wider UK economy and key facts about the industry.

Commenting on the publication, BIVDA’s Chief Executive Doris-Ann Williams MBE said:

“The forthcoming General Election has provided us with a valuable opportunity to remind Parliamentary candidates of the value of IVDs.

“Around 70% of clinical decisions are made using an IVD. Therefore, we urge the next Government to continue to work with the IVD industry, to increase the adoption of IVDs and improve outcomes for both patients and the NHS”.

BIVDA’s 2017 General Election Manifesto can be read here.


BIVDA's response to the 2019 General Election result

Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...

Read More >

UK life sciences industry commitment to fighting COVID-19 and supporting NHS patients

Please see attached a joint statement from BIVDA, the ABHI, BIA and ABPI on our commitment to suppor...

Read More >

BIVDA Unveils New Website

The British In Vitro Diagnostics Association (BIVDA) has today unveiled its new website including a ...

Read More >

BIVDA Response to the Life Sciences Sector Deal

Commenting on the publication of the Life Sciences Sector Deal (6th December 2017), BIVDA’s Chief E...

Read More >

BIVDA Board elects Darren Stenlake as Chair

Darren Stenlake (Sysmex UK Ltd) has been elected as Chairman of the BIVDA Board

Read More >

New report highlights the value of near patient testing

BIVDA launches new report on the value of near patient testing

Read More >